286 related articles for article (PubMed ID: 27156069)
21. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
22. Management of gastric cancer in older adults.
Matthaiou C; Papamichael D
J Geriatr Oncol; 2017 Nov; 8(6):403-406. PubMed ID: 28778419
[TBL] [Abstract][Full Text] [Related]
23. Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Cai G; Yang Z; Cao L; Hu C; Guo X; Sun J; Chen J
Breast Cancer; 2016 Sep; 23(5):732-9. PubMed ID: 26267412
[TBL] [Abstract][Full Text] [Related]
24. Targeted therapies for gastric cancer: current status.
Yoong J; Michael M; Leong T
Drugs; 2011 Jul; 71(11):1367-84. PubMed ID: 21812503
[TBL] [Abstract][Full Text] [Related]
25. Management of gastric cancer.
Ku GY; Ilson DH
Curr Opin Gastroenterol; 2014 Nov; 30(6):596-602. PubMed ID: 25197781
[TBL] [Abstract][Full Text] [Related]
26. The impact of concomitant genomic alterations on treatment outcome for trastuzumab therapy in HER2-positive gastric cancer.
Lee JY; Hong M; Kim ST; Park SH; Kang WK; Kim KM; Lee J
Sci Rep; 2015 Mar; 5():9289. PubMed ID: 25786580
[TBL] [Abstract][Full Text] [Related]
27. Advanced gastric adenocarcinoma: optimizing therapy options.
Mizrak Kaya D; Harada K; Shimodaira Y; Amlashi FG; Lin Q; Ajani JA
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):263-271. PubMed ID: 28094573
[TBL] [Abstract][Full Text] [Related]
28. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ
Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238
[TBL] [Abstract][Full Text] [Related]
29. Current and Future Therapies for Advanced Gastric Cancer.
Davidson M; Okines AF; Starling N
Clin Colorectal Cancer; 2015 Dec; 14(4):239-50. PubMed ID: 26524924
[TBL] [Abstract][Full Text] [Related]
30. Recent Strategies for Treating Stage IV Gastric Cancer: Roles of Palliative Gastrectomy, Chemotherapy, and Radiotherapy.
Izuishi K; Mori H
J Gastrointestin Liver Dis; 2016 Mar; 25(1):87-94. PubMed ID: 27014758
[TBL] [Abstract][Full Text] [Related]
31. Advances of Molecular Targeted Therapy in Gastric Cancer.
Cetin B; Gumusay O; Cengiz M; Ozet A
J Gastrointest Cancer; 2016 Jun; 47(2):125-34. PubMed ID: 26875080
[TBL] [Abstract][Full Text] [Related]
32. Medical management of gastric cancer: a 2017 update.
Charalampakis N; Economopoulou P; Kotsantis I; Tolia M; Schizas D; Liakakos T; Elimova E; Ajani JA; Psyrri A
Cancer Med; 2018 Jan; 7(1):123-133. PubMed ID: 29239137
[TBL] [Abstract][Full Text] [Related]
33. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
[TBL] [Abstract][Full Text] [Related]
34. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Yu W
Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.
Seshadri RA; Glehen O
World J Gastroenterol; 2016 Jan; 22(3):1114-30. PubMed ID: 26811651
[TBL] [Abstract][Full Text] [Related]
36. Updated evidence on adjuvant treatments for gastric cancer.
Kanda M; Kodera Y; Sakamoto J
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1549-60. PubMed ID: 26414453
[TBL] [Abstract][Full Text] [Related]
37. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
38. Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.
Smyth EC; Tarazona N; Chau I
Immunotherapy; 2014; 6(11):1177-86. PubMed ID: 25496333
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
[TBL] [Abstract][Full Text] [Related]
40. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
